DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.A branded formulation is marketed in the U.S. as Pediarix by GlaxoSmithKline. == References ==
The US Centers for Disease Control and Prevention recommends polio vaccination boosters for travelers and those who live in countries where the disease is endemic.In July 2022, the US state of New York reported a polio case for the first time in almost a decade in the country. Health officials said the person, an unvaccinated young adult who had not recently travelled abroad, first showed symptoms a month earlier and eventually developed paralysis. The New York State Health Commissioner subsequently attributed this to a vaccine-derived strain of the virus. This strain had also had been detected in wastewater in New York City. As of September 13, 2022 vaccine-derived polio is confirmed to be circulating locally in Rockland County and may be circulating locally in Orange County and may be circulating locally. Western Pacific
In 2000, polio was declared to have been officially eliminated in 37 Western Pacific countries, including China and Australia.Despite eradication ten years earlier, an outbreak was confirmed in China in September 2011, involving a strain common in Pakistan.In September 2019, the Department of Health of the Philippines declared a polio outbreak in the country after a single case in a 3-year-old girl. The outbreak was declared to be ended during June 2021. In December 2019, acute poliomyelitis was confirmed in an infant in Sabah state, Borneo, Malaysia. Subsequently, a further three polio cases were reported, with the last case reported in January 2020. Prior to this, Malaysia had been declared polio-free in 2000. WHO declared an end to the outbreak in September 2021.